Search research articles
Contact Us
Filters
Showing results (171-180 of 235) with videos related to
Page
of 24
Sort By:
Communications Medicine
|
April 24, 2025
Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma
David Tougeron, Christophe Louvet, Jérôme Desramé, et al.
International Journal of Cancer
|
June 20, 2025
Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer
Anouchka Modesto, Sophie Gibert, Caroline Delmas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 8, 2024
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort
Antoine Lebeaud, Leony Antoun, Jane-Rose Paccard, et al.
Cancer Research
|
June 11, 2015
Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy
Pauline Maby, David Tougeron, Mohamad Hamieh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 18, 2021
Prognostic factors of colorectal cancer patients with brain metastases
Pauline Roussille, Marie Auvray, Damien Vansteene, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2019
Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial
Pascal Hammel, Portales Fabienne, Laurent Mineur, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2020
Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial' [European Journal of Cancer, Volume 124 (January 2020) Pages 91-101]
Pascal Hammel, Fabienne Portales, Laurent Mineur, et al.
International Journal of Cancer
|
July 5, 2023
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study
Pauline Marolleau, David Tougeron, Benoit Allignet, et al.
British Journal of Cancer
|
May 14, 2024
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases
Thomas Aparicio, Julie Henriques, Magali Svrcek, et al.
Cancers
|
April 12, 2022
Prognostic Value of <i>Fusobacterium nucleatum</i> after Abdominoperineal Resection for Anal Squamous Cell Carcinoma
Marc Hilmi, Cindy Neuzillet, Jérémie H Lefèvre, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 235) with videos related to
Sort By:
Page
of 24
Communications Medicine
|
April 24, 2025
Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma
David Tougeron, Christophe Louvet, Jérôme Desramé, et al.
International Journal of Cancer
|
June 20, 2025
Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma-based collection of 77 patients with locally advanced unresectable esophageal cancer
Anouchka Modesto, Sophie Gibert, Caroline Delmas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 8, 2024
Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort
Antoine Lebeaud, Leony Antoun, Jane-Rose Paccard, et al.
Cancer Research
|
June 11, 2015
Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy
Pauline Maby, David Tougeron, Mohamad Hamieh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 18, 2021
Prognostic factors of colorectal cancer patients with brain metastases
Pauline Roussille, Marie Auvray, Damien Vansteene, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2019
Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial
Pascal Hammel, Portales Fabienne, Laurent Mineur, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2020
Erratum to 'Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial' [European Journal of Cancer, Volume 124 (January 2020) Pages 91-101]
Pascal Hammel, Fabienne Portales, Laurent Mineur, et al.
International Journal of Cancer
|
July 5, 2023
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study
Pauline Marolleau, David Tougeron, Benoit Allignet, et al.
British Journal of Cancer
|
May 14, 2024
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases
Thomas Aparicio, Julie Henriques, Magali Svrcek, et al.
Cancers
|
April 12, 2022
Prognostic Value of <i>Fusobacterium nucleatum</i> after Abdominoperineal Resection for Anal Squamous Cell Carcinoma
Marc Hilmi, Cindy Neuzillet, Jérémie H Lefèvre, et al.
Page
of 24